Mechanism of Glycosaminoglycan-Mediated Bone and Joint Disease

This publication has 45 references indexed in Scilit:

• Ex vivo interleukin 1 receptor antagonist production on lipopolysaccharide stimulation is associated with rheumatoid arthritis and with joint damage
  Annals of the Rheumatic Diseases, 2007
• Acid sphingomyelinase inhibition suppresses lipopolysaccharide‐mediated release of inflammatory cytokines from macrophages and protects against disease pathology in dextran sulphate sodium‐induced colitis in mice
  Immunology, 2007
• Cutaneous mucinosis associated with dermatomyositis and nephrogenic fibrosing dermopathy: fibroblast hyaluronan synthesis and the effect of patient serum
  British Journal of Dermatology, 2007
• Acid Sphingomyelinase Is Required for Lipid Raft TLR4 Complex Formation
  Surgical Infections, 2007
• Restricted upper extremity range of motion in mucopolysaccharidosis type I: no response to one year of enzyme replacement therapy
  Journal of Inherited Metabolic Disease, 2006
• Outcome after three years of laronidase enzyme replacement therapy in a patient with Hurler syndrome
  Journal of Inherited Metabolic Disease, 2006
• Sphingosine-1-phosphate stimulates rat primary chondrocyte proliferation
  Biochemical and Biophysical Research Communications, 2006
• The Urinary Excretion of Glycosaminoglycans and Heparan Sulphate in Lupus Nephritis
  Clinical Rheumatology, 2002
• Regulation of Rheumatoid Synovial Cell Growth by Ceramide
  Biochemical and Biophysical Research Communications, 2000
• Mucopolysaccharidosis Type VI in Rats: Isolation of cDNAs Encoding Arylsulfatase B, Chromosomal Localization of the Gene, and Identification of the Mutation
  Genomics, 1995